STSS - sharpstechnology.com Operating income before deduction of amortization
Intense pricing competition with global suppliers is impacting dynamics, and at GURU.Markets, the absolute EBITDA level demonstrates this dependency, where 0.00 shapes the current metric. A revenue shortfall coupled with high R&D expenses is leading to the depletion of reserves. Meanwhile, Sharps Technology, Inc. (STSS) maintains pricing power thanks to its low dead-space syringes, which eliminate medication waste.
Summary analytical data breakdowns for Sharps Technology (STSS)
- stock quotes and analyst forecast:
- market capitalization statistics:
- balance sheet equity data:
- debt level and financial liquidity data:
Aggregate Debt to Capital Sharps Technology, Inc.|STSS - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Sharps Technology Inc|STSS - Company Total Debt|Debts to Book Capitalization Sharps Technology, Inc.|STSS - Company Long-Term Debt|Company Current Liabilities Sharps Technology, Inc.|Immediate Liquidity sharpstechnology.com
- earnings and valuation multiples indicators:
STSS - Company Net Income|Net Profit Forecast Sharps Technology, Inc.|STSS - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Sharps Technology Inc|STSS - Price/Earnings to Growth Ratio|Total Company Value to Operating Income Before Depreciation Ratio Sharps Technology, Inc.|STSS - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters Sharps Technology, Inc.|STSS - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months sharpstechnology.com|STSS - Earnings growth in current year|Earnings growth forecast for next year Sharps Technology, Inc.
Fundamental company valuation:STSS (Sharps Technology, Inc.)
This indicator measures the net cash flow generated by the core business before accounting for asset depreciation, allowing for an assessment of real solvency and the internal efficiency of the operating model. An analysis of the operating result of Sharps Technology, Inc. (STSS) before depreciation and amortization demonstrates how successfully the company is scaling the production of self-destructing syringes and overcoming pressure from major competitors within current medical safety standards.
Competitors of Sharps Technology, Inc. (STSS)
Income before deduction of interest, taxes and amortization ISRG|Danaher Corp. - Operating profit EBITDA|Operating income before deduction of amortization bd.com BDX|STERIS (STE) - Profit before payment of interest, taxes and amortization|Operating profit before amortization WST|Profit before payment of interest, taxes and amortization Baxter Corp|Masimo Inc. (MASI) - Operating income before deduction of amortization|Operating profit before deduction of amortization STVN (Stevanato Group S.p.A.)|Company profit before taxes, interest and amortization TFX|Profit before payment of interest, taxes and amortization Merit Medical MMSI|Income before deduction of interest, taxes and amortization NVST|ICUI: Operating profit before deduction of amortization|XRAY - Operating profit EBITDA|LeMaitre Vascular, Inc. (LMAT) - Profit before payment of interest, taxes and amortization|Operating profit before deduction of amortization atricure.com|STAA (STAAR Surgical) - Operating profit EBITDA|Profit before interest, taxes and amortization ChromaDex Corp NAGE|Profit before payment of interest, taxes and amortization ZimVie Dental (ZIMV)|AngioDynamics Inc. - Operating profit before amortization|Cerus Corporation - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization TKNO (teknova.com)|MGRM - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization InfuSystem Holdings INFU|Utah Medical (UTMD) - Profit before payment of interest, taxes and amortization|KRMD - Operating income before deduction of amortization|NYXH (Nyxoah S.A.) - Operating profit EBITDA|MBOT: Income before deduction of interest, taxes and amortization|Operating profit EBITDA PDEX|Operating profit EBITDA Zentek Ltd (ZTEK)|Profit before payment of interest, taxes and amortization Elutia Corp ELUT|Income before deduction of interest, taxes and amortization MLSS|NXGL - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization RVP|Harvard Bioscience (HBIO) - Profit before payment of interest, taxes and amortization|FEMY - Operating income before deduction of amortization|Operating profit before deduction of amortization MHUA|POAI: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization CJMB (Callan JMB Inc)|Company profit before taxes, interest and amortization ATRI|Operating profit EBITDA NURO (NeuroMetrix)
